In mice treated with VDR 4-1 and 1,25-D3 l at physiologic dose (0.6 μg/kg), there were significant attenuations of TAC-induced cardiac hypertrophy compared with their vehicle treated littermates. This evidence concerns the gene VDR and cardiac hypertrophy.